GlassScriptPhysician profile
Terry S Edwards
NPI 1811912991
$1,976.07
in general payments reported to CMS, 2019-2025
16 companies · $586 in 2025
The $586 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.84 · 2020: $78.41 · 2021: $85.00 · 2022: $209 · 2023: $257 · 2024: $683 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,526.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $834.91 | 2022-2025 | Vraylar, Qulipta, Ubrelvy |
| Lilly USA, LLC | $291.95 | 2021-2025 | Zepbound, Jardiance, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $246.20 | 2019-2025 | Airsupra, Farxiga |
| Pfizer INC. | $142.31 | 2019-2023 | |
| Exact Sciences Corporation | $136.24 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $96.19 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Biohaven Pharmaceutical Holding Company LTD. | $41.08 | 2022 | |
| Corcept Therapeutics | $39.86 | 2025 | Korlym |
| Janssen Pharmaceuticals, INC | $26.08 | 2025 | Spravato |
| Edwards Lifesciences Corporation | $20.31 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Inspire Medical Systems, INC. | $20.17 | 2024 | Inspire |
| Medtronic, INC. | $18.14 | 2025 | Kyphon Express II Kyphopak Tray |
| Astellas Pharma US INC | $16.64 | 2023 | Veozah |
| Novartis Pharmaceuticals Corporation | $16.48 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $16.30 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $13.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.